Sixty-two patients with glaucoma and 41 age-similar control subjects free of eye disease were tested as part of a multicenter longitudinal study
30 in three cities: Bloomington and Indianapolis, Indiana (Indiana University School of Optometry) and New York City, New York (SUNY College of Optometry).
Experiment 1 tested 20 glaucoma patients ages 46 to 84 years (mean 62.8, SD 10.4) and 10 age-similar control subjects ages 47 to 77 years (mean 57.2, SD 8.1). All were experienced with perimetry using clinical systems and had participated in prior studies with custom testing stations presenting custom stimuli. The time between visits ranged from 2 to 28 days (mean 11.5, SD 8.5).
Experiments 2 and 3 analyzed data from 51 patients with glaucoma and 37 controls; 9 patients and 6 controls had also participated in experiment 1. The age range was 47 to 85 years (mean 68.6, SD 8.5) for the patients with glaucoma and 47 to 77 years (mean 61.9, SD 8.3) for the controls. The time between visits ranged from 10 to 35 weeks (mean 17, SD 6).
For each patient, the diagnosis of glaucoma was made by the treating clinician based on a comprehensive ophthalmic examination including medical history, refraction, best-corrected visual acuity, slit lamp biomicroscopy (including gonioscopy), applanation tonometry, dilated fundoscopy, stereoscopic ophthalmoscopy of the optic disc with a 78-diopter (D) lens, stereo photos of the optic nerve, and optic nerve imaging. A wide range of visual field damage was represented: Mean deviation (MD) for size III perimetry ranged from −18.4 to +1.3 dB (mean −4.9, SD 5.0 dB), and pattern standard deviation (PSD) ranged from 1.6 to 15.7 dB (mean 6.3, SD 4.1 dB).
For each control subject, one of the clinicians participating in the study reviewed the results of a recent comprehensive eye examination and data in the study chart to ensure that the person was found to be free of eye disease. MD for size III perimetry ranged from −2.5 to +1.4 dB (mean 0.0, SD 0.9 dB), and PSD ranged from 0.9 to 2.1 dB (mean 1.5, SD 0.3 dB).
Inclusion criteria for both groups were as follows: age 45 to 85 years at time of enrollment, absence of known eye disease during a comprehensive eye examination within 2 years (except for glaucoma in the patient group), best corrected visual acuity of 20/20 or better (20/30 over age 70), spherical equivalent within −6 D to +2 D, cylinder correction within 3 D, clear ocular media. Exclusion criteria were an ocular or systemic disease (except for glaucoma in the patient group) known to affect the visual field (e.g., diabetic retinopathy, prior vein occlusion, macular degeneration, degenerative myopia, migraines), history of intraocular surgery (except uncomplicated cataract surgery more than a year before enrollment or past glaucoma surgery in the patient group), use of medications known to affect vision, inability to produce consistent data on perimetry, and pupil diameter less than 3 mm. Additional exclusion criteria for patients with glaucoma were intraocular pressure (IOP) > 30 mm Hg on a recent clinic visit and failure to attend routine clinic visits. Additional exclusion criteria for controls were IOP > 21 mm Hg, a first-degree relative with glaucoma, narrow angles and/or peripheral anterior synechiae, abnormal optic disc appearance (definite signs consistent with glaucoma, such as regional rim narrowing or notching or wedge-shaped retinal nerve fiber layer defects), and abnormal fundus appearance.
Institutional review board (IRB) approval was obtained from IRBs at Indiana University and SUNY College of Optometry. Written informed consent was obtained from each participant after explanation of the procedures and goals of the study before testing began.